|
See related Konakion MM information |
|
|
|
Manufacturer |
Roche |
|
Distributor |
Hong Kong: DKSH/Macau: Firma Chun Cheong |
|
Contents |
Synthetic vit K1 (phytomenadione) |
|
Indications |
Haemorrhage during severe hypoprothrombinaemia or overdose w/ anticoagulant. Hypovitaminosis K. |
|
Dosage |
Severe, life-threatening haemorrhage 10-20 mg by slow IV. Hemorrhage or threatened hemorrhage in newborn or premature infant Prophylaxis: 1 mg IM immediately post-partum. Therapy: 1 mg/kg daily IM for 1-3 days. |
|
Adverse Drug Reactions |
Rarely, severe shock-like reactions, phlebitis, inj site irritation.
View ADR Monitoring Form |
|
Drug Interactions |
Dicoumarol & its derivatives.
View more drug interactions with Konakion MM |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
ATC Classification |
B02BA01 - phytomenadione ; Belongs to the class of vitamin K. Used in the treatment of hemorrhage. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Konakion MM injection |
|
Konakion MM 10 mg/1 mL x 5's |
|
|
Konakion MM paed injection |
|
Konakion MM 2 mg/0.2 mL x 5's |
|
|
|
Manufacturer: |
Roche |
|
Distributor: |
Hong Kong: DKSH
Macau: Firma Chun Cheong |
|
|
|
